Application of electronic clinical pathway in the Mammotome biopsy of benign breast tumor

Abstract

Objective To compare the differences between conventional Mammotome biopsy of benign breast tumor and Mammotome biopsy under the electronic clinical pathway,in order to provide basis for Mammotome biopsy of benign breast tumor under clinical pathway.Methods 160 patients with benign breast tumor in affiliated Hospital of Binzhou Medical College from January 2010 to December 2011 were divided into the control group (80 patients treated with conventional Mammotome biopsy) and the observational group (80 patients treated with Mammotome biopsy under clinical pathway).Patients' waiting days before surgery,days in hospital,total cost,obedience,health knowledge,postoperative complications and satisfaction between two groups were compared.Results Days before surgery in the observational group were (1.25 ± 0.33),and days in hospital were (4.28 ± 1.52),both of which were shorter than those in the control group (2.44 ± 0.65),(6.02 ± 4.12).The differences were statistically significant (t =7.48,9.86,respectively ; P ＜ 0.05).Total cost in the observational group was (4 758.48 ± 686.34) yuan,fewer than that in the control group which was (4 998.76 ± 778.32) yuan,and the differences were statistically significant (t =3.46,P ＜ 0.05).Compared with the control group,the observational group had better obedience rate (97.5％ vs 85％),better mastering of health knowledge (97.5％ vs 82.5％),and higher satisfaction (97.5％ vs 85％).The differences were statistically significant (x2 =7.83,10.0,7.83,respectively ; P ＜ 0.05).Conclusions Mammotome biopsy under clinical pathway can further improve patients' obedience and satisfaction,reduce days in hospital,total cost and postoperative complications,thus should be promoted actively. Key words: Clinical pathway; Mammotome; Biopsy